Gene therapy reverses ED in animal model - AnabolicMinds.com

Gene therapy reverses ED in animal model

  1. Registered User
    TheCrownedOne's Avatar
    Stats
    6'3"  215 lbs.
    Join Date
    Dec 2004
    Posts
    1,362
    Answers
    0
    Rep Power
    801

    Gene therapy reverses ED in animal model


    Gene Therapy Delivery Of Nerve Growth Factors Reverses Erectile Dysfunction In Animal Model
    ScienceDaily: Gene Therapy Delivery Of Nerve Growth Factors Reverses Erectile Dysfunction In Animal Model

    Science Daily SEATTLE, June 2 -- Rats with erectile dysfunction, or ED, that were injected with a gene therapy vector containing either of two nerve growth factors were able to regain normal function after four weeks, according to a study conducted by University of Pittsburgh School of Medicine researchers. These findings are being presented at the 10th annual meeting of the American Society of Gene Therapy, which is convening May 30 to June 3 at the Washington State Convention & Trade Center, Seattle.

    ED is the repeated inability to achieve or maintain an erection necessary for sexual intercourse. Because of the variability of symptoms, estimates of the incidence of ED vary but range from 15 million to 30 million affected men in the United States. ED is frequently associated with damage to the cavernous nerve that results from surgery for prostate cancer. Even if a patient receives a nerve-sparing procedure during surgery, recovery from ED after radical prostatectomy may take a long time.

    In this study, which was led by Joseph C. Glorioso, III, Ph.D., chair of the department of biochemistry and molecular genetics, and Joel Nelson, M.D., chair of the department of urology, University of Pittsburgh School of Medicine, researchers inserted either the gene for the glial cell line derived neurotrophic factor (GDNF) or the GDNF family ligand (neurturin) into a genetically engineered herpes simplex virus (HSV). They then injected either of the recombinant viruses into the damaged cavernous nerve of rats. GDNF is an important nerve growth promoter and has been shown in other studies to contribute to survival and regeneration of penile nerves. Neurturin also is a nerve growth factor closely related to GDNF. Control mice received only the virus without the GDNF or neurterin genes inserted.

    Four weeks after the treatment, rats administered HSV-GDNF exhibited significant recovery of intracavernous pressure (ICP) and systemic arterial pressure (AP) compared with rats treated with the control virus or untreated mice with ED. Rats treated with HSV-neurturin also exhibited significant recovery of ICP and AP compared with the control or untreated mice at four weeks after treatment. Fluorescent protein studies also showed that the delivered genes had been effectively incorporated into the target nerve cells.

    According to Dr. Glorioso, HSV delivery of GDNF or neurturin presents a potentially important new approach for the treatment of ED. "Because the herpes virus persists in the nerve cell for as long as it is alive and nerve cells typically do not reproduce, this represents the first-ever demonstration of a long-term treatment for ED that does not rely on the chronic administration of drugs that can have potentially harmful side effects," he explained.

    In addition to Drs. Glorioso and Nelson, others involved in the study included, William F. Goins, Ph.D., Shaohua Huang, Ph.D., James B. Wechuck, Ph.D., and Darren P. Wolfe, Ph.D., department of molecular genetics and biochemistry, University of Pittsburgh School of Medicine; Ryuichi Kato, M.D., Naoki Yoshimura, M.D., Christian H. Coyle, M.D., Michael B. Chancellor, M.D., and Fernando de Miguel, M.D., department of urology, University of Pittsburgh School of Medicine; and Taiji Tsukamoto, M.D., department of urology, Sapparo Medical University School of Medicine, Japan.

    Note to Editors: This is Abstract No. 986, which can be found online at: American Society of Gene Therapy Abstracts2View™: Login Page

    Note: This story has been adapted from a news release issued by University of Pittsburgh Schools of the Health Sciences.

  2. Banned
    sugamber's Avatar
    Join Date
    Jun 2007
    Posts
    24
    Answers
    0
    Rep Power
    0

    good deal !!!!!!!!!!!!!!!!!!!!!!
  3. Registered User
    TheCrownedOne's Avatar
    Stats
    6'3"  215 lbs.
    Join Date
    Dec 2004
    Posts
    1,362
    Answers
    0
    Rep Power
    801

    Quote Originally Posted by sugamber View Post
    good deal !!!!!!!!!!!!!!!!!!!!!!
    Haha, BANNED!!!!!!!!!!!!!! GOOD DEAL!!!!!!!!!!!!
    •   
       

Similar Forum Threads

  1. Resveratrol reduces colon tumor formation in animal model
    By yeahright in forum News and Articles
    Replies: 6
    Last Post: 10-30-2007, 12:18 AM
  2. To China For Gene Therapy Cancer Drug
    By yeahright in forum News and Articles
    Replies: 0
    Last Post: 07-06-2007, 02:10 AM
  3. Inositol compounds prevent Alzheimer's disease in mouse model
    By yeahright in forum News and Articles
    Replies: 0
    Last Post: 06-14-2006, 05:11 PM
  4. Gene Therapy with Coffee and Tea
    By Smoky in forum News and Articles
    Replies: 0
    Last Post: 05-24-2006, 05:41 PM
  5. Mighty Mouse, for real, courtesy of gene therapy
    By khafra in forum General Chat
    Replies: 2
    Last Post: 05-27-2004, 09:31 AM

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts
  •  
Log in
Log in